Track the 东诚药业 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东诚药业 has recorded 1 reports. Market capitalisation: €10.5bn. The latest transaction was filed on 17 May 2022 (Sale). Among the most active insiders: 吴丽娣. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Dongcheng Pharmaceutical is a company focused on the health and pharmaceutical sector, specializing in the research and development of medications. It is listed on the XSHE market.